By Colin Kellaher
Dynavax Technologies said it inked a $280 million accelerated share-repurchase agreement with Goldman Sachs.
The biopharmaceutical Dynavax on Monday said it expects an initial delivery of about 6.1 million shares, representing roughly 80% of the deal, with final settlement in the first quarter.
The Emeryville, Calif., company, which has nearly 131.5 million shares outstanding and has a market capitalization topping $1.7 billion, said it is making the accelerated buyback as part of the $200 million buyback program it announced last week, adding that it will have $100 million remaining under the program.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
November 11, 2024 08:35 ET (13:35 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments